ProCE Banner Activity

Preview of ASCO 2017: Top Expert-Selected Studies

Conference Coverage
Clinical Thought
Look for these important studies at the upcoming Clinical Oncology meeting in Chicago. Be sure to also check our Web site frequently for downloadable PowerPoint slides featuring key presented data.

Released: May 31, 2017

Expiration: May 30, 2018

No longer available for credit.

Share

Faculty

Sara Hurvitz

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants by

AbbVie

Amgen, Inc.

AstraZeneca

Celgene

Genentech Roche Virology

Halozyme

Incyte

Merck Oncology

Faculty Disclosure

Primary Author

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Sara Hurvitz, MD, FACP, has disclosed that she has received contracted research from Amgen, Bayer, Boehringer Ingelheim, Dignitana, Genentech/Roche, Lilly, Merrimack, Novartis, Pfizer, OBI Pharma, and Seattle Genetics.